会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Calcitonin receptor binding reagents
    • 降钙素受体结合试剂
    • US6083480A
    • 2000-07-04
    • US847007
    • 1997-05-01
    • Richard T. DeanLarry R. BushDaniel A. PearsonJohn Lister-James
    • Richard T. DeanLarry R. BushDaniel A. PearsonJohn Lister-James
    • A61K51/00A61K38/00A61K38/23A61K49/00A61K51/08A61P35/00C07B59/00C07K14/585A61M36/14
    • C07K14/585A61K38/00
    • This invention relates to radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic and radiotherapeutic agents. Specifically, the invention relates to calcitonin receptor binding compounds, preferably peptides, derivatives and analogues of calcitonin, and embodiments of such compounds radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such compounds, particularly peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to calcitonin receptor binding peptide derivatives and analogues of calcitonin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to calcitonin receptor binding peptide derivatives and analogues of calcitonin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
    • 本发明涉及放射治疗试剂和肽,放射诊断试剂和肽,以及用于产生标记的放射诊断和放射治疗剂的方法。 具体地,本发明涉及降钙素受体结合化合物,优选降钙素的肽,衍生物和类似物,以及用放射性同位素放射性标记的这种化合物的实施方案,以及用于制备,放射性标记和使用这些化合物的方法和试剂盒,特别是用于放射诊断和 放射治疗目的。 本发明具体涉及降钙素受体结合肽衍生物和用锝-99m放射性标记的降钙素的类似物及其用作闪烁照相成像剂。 本发明还具体涉及降钙素受体结合肽衍生物和放射性标记的细胞毒性放射性同位素如铼-186(186Re)和铼-188(188Re)用作放射治疗剂的降钙素的类似物。 还提供了用于在哺乳动物体内制造,放射性标记和诊断和治疗上使用这些肽的方法和试剂盒。
    • 5. 发明授权
    • Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
    • 放射性标记的血管活性肠肽用于诊断和治疗
    • US6007792A
    • 1999-12-28
    • US930845
    • 1998-01-21
    • Richard T. DeanDaniel A. PearsonJohn Lister-JamesEdgar R. Civitello
    • Richard T. DeanDaniel A. PearsonJohn Lister-JamesEdgar R. Civitello
    • A61K51/00A61K51/08A61P35/00A61P43/00C07B59/00C07K7/06C07K14/575C07K14/775A61M36/14
    • C07B59/008A61K51/08A61K51/088C07K14/775C07K7/06A61K2121/00A61K2123/00
    • This invention relates to radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic and radiotherapeutic agents. Specifically, the invention relates to vasoactive intestinal peptide receptor binding peptides, derivatives and analogues of vasoactive intestinal peptide, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to vasoactive intestinal peptide receptor binding peptide derivatives and analogues of vasoactive intestinal peptide radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to vasoactive intestinal peptide receptor binding peptide derivatives and analogues of vasoactive intestinal peptide radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
    • PCT No.PCT / US96 / 04308 Sec。 371日期1998年1月21日 102(e)日期1998年1月21日PCT 1996年3月29日PCT公布。 WO96 / 30055 PCT公开 日期1996年10月3日本发明涉及放射治疗试剂和肽,放射诊断试剂和肽,以及用于制备标记的放射性诊断和放射治疗剂的方法。 具体地,本发明涉及血管活性肠肽受体结合肽,血管活性肠肽的衍生物和类似物以及用放射性同位素放射性标记的这些肽的实施方案,以及用于制备放射性标记和使用这些肽用于放射诊断和放射治疗目的的方法和试剂盒 。 本发明具体涉及放射性标记有锝-99m的血管活性肠肽受体结合肽衍生物和血管活性肠肽的类似物及其用作闪烁照相成像剂。 本发明还特别涉及放射性标记用细胞毒性放射性同位素如铼-186(186Re)和铼-188(188Re)用作放射治疗剂的血管活性肠肽受体结合肽衍生物和血管活性肠肽的类似物。 还提供了用于在哺乳动物体内制造,放射性标记和诊断和治疗上使用这些肽的方法和试剂盒。
    • 7. 发明授权
    • Technetium-99m labeled peptides for imaging
    • 锝-99m标记肽成像
    • US5951964A
    • 1999-09-14
    • US341537
    • 1995-01-26
    • Richard T. DeanJohn Lister-James
    • Richard T. DeanJohn Lister-James
    • A61K51/08A61K38/00
    • A61K51/088A61K51/082A61K2123/00
    • This invention relates to radiolabeled reagents, including specific-binding peptide embodiments thereof, and methods for producing and using such reagents. Specifically, the invention relates to reagents for preparing scintigraphic imaging agents for imaging sites in a mammalian body. Reagents, methods and kits for making such reagents, and methods for using such reagents labeled with technetium-99m (Tc-99m) via Tc-99m binding moieties comprising said reagents, are provided. In particular, the specific-binding peptides and Tc-99m binding moieties comprising the reagents of the invention are covalently linked to a polyvalent linker moiety, so that the polyvalent linker moiety is covalently linked to a multiplicity of the specific-binding peptides, and the Tc-99m binding moieties are covalently linked to a plurality of the specific-binding peptides, the polyvalent linker moiety, or to both the specific-binding peptides and the polyvalent linker moiety.
    • PCT No.PCT / US93 / 05372 Sec。 371日期1995年1月26日 102(e)日期1995年1月26日PCT提交1993年6月4日PCT公布。 出版物WO93 / 25244 日期1993年12月23日本发明涉及放射性标记的试剂,包括其特异性结合肽实施方案,以及制备和使用这些试剂的方法。 具体地,本发明涉及用于制备用于哺乳动物体内成像位点的闪烁照相成像剂的试剂。 提供了用于制备这些试剂的试剂,方法和试剂盒,以及通过包含所述试剂的Tc-99m结合部分使用由锝-99m(Tc-99m)标记的试剂的方法。 特别地,包含本发明试剂的特异性结合肽和Tc-99m结合部分与多价接头部分共价连接,使得多价接头部分与多种特异性结合肽共价连接, Tc-99m结合部分共价连接到多个特异性结合肽,多价接头部分,或特异性结合肽和多价接头部分。